F104 Hair Disorders Made Easier
DESCRIPTION
This session will empower dermatologists to provide a practical approach to hair disorders, focused on the key differential diagnosis and types of therapy. From getting the most out of your biopsy reports and utilizing trichoscopy to learning the best therapeutic pearls from expert alopecia specialists, this session will be a "one stop" for all things you want to learn about diagnosing and managing patients with non-scarring and scarring alopecia.
LEARNING OBJECTIVES
Develop an approach to assessing and monitoring patients with hair loss disorders
Formulate therapeutic approaches and develop effective treatment plans for patients with scarring and non-scarring alopecia
Utilize therapeutic pearls based on expert clinical experience
SCHEDULE
3:30 PM
Hair Transplantation: When to consider it and FAQs for the dermatologist
Nicole Elaine Rogers, MD, FAAD
3:40 PM
Getting the most from your alopecia pathology reports
Lynne J. Goldberg, MD, FAAD
3:50 PM
Trichoscopy 101 for Alopecia Diagnoses
Rodrigo Pirmez, MD
4:00 PM
Treatment of Female Pattern Hair Loss
Paulo Müller Ramos, MD, IFAAD
4:10 PM
Frontal Fibrosing Alopecia: My Therapeutic Approach
Daniel Asz-Sigall, MD, IFAAD
4:20 PM
Treatment of Lichen Planopilaris
Isabella Doche, MD, PhD, IFAAD
4:30 PM
Treatment of Male Androgenetic Alopecia
Luis Enrique Sanchez Duenas, MD
4:40 PM
Mesotherapy and Botox for Non-Scarring Hair Loss
Daniel Melo, MD, MS, PhD, IFAAD
4:50 PM
Treatment of Neutrophilic Scarring Alopecia
Lidia Rudnicka, MD, PhD, IFAAD
5:00 PM
Alopecia Areata: JAK Inhibitor Treatment Pearls
Anastasia Therianou, MD, PhD, IFAAD
5:10 PM
Lasers, Lights, and PRP for the Treatment of Alopecia
Joseph W. Fakhoury, MD, FAAD
5:20 PM
Questions and Answers
DIRECTOR
Joseph W. Fakhoury, MD, FAAD
SPEAKERS
Daniel Asz-Sigall, MD, IFAAD
Trichology Clinic, Dr Manuel Gea Gonzalez General Hospital, Mexico City. Mexico
Isabella Doche, MD, PhD, IFAAD
Lynne J. Goldberg, MD, FAAD
Daniel Melo, MD, MS, PhD, IFAAD
Paulo Müller Ramos, MD, IFAAD
São Paulo State University - UNESP
Rodrigo Pirmez, MD
Santa Casa da Misericórdia do Rio de Janeiro, Brazil
Nicole Elaine Rogers, MD, FAAD
Tulane University School of Medicine
Lidia Rudnicka, MD, PhD, IFAAD
Medical University of Warszaw
Luis Enrique Sanchez Duenas, MD
Anastasia Therianou, MD, PhD, IFAAD
DISCLOSURES
Daniel Asz-Sigall, MD, IFAAD
No financial relationships exist with ineligible companies.
Isabella Doche, MD, PhD, IFAAD
Ache Laboratório Farmaceuticso S.A. – Speaker/Faculty Education(Fees); Cantabria Labs – Speaker/Faculty Education(Fees); Fotofinder – Other(Equipment); GlaxoSmithKline Immunology – Speaker/Faculty Education(Fees); L'Oreal – Speaker/Faculty Education(Fees); Mantecorp – Consultant (1099 relationship)(Fees); Panalab – Speaker/Faculty Education(Fees); Pfizer Inc. – Advisory Board(Fees), Speaker/Faculty Education(Fees); Pierre Fabre – Speaker/Faculty Education(Fees); TheraSkin Farmacêutica – Consultant (1099 relationship)(Fees);
Joseph W. Fakhoury, MD, FAAD
Veradermics – Consultant (1099 relationship)(Honoraria);
Lynne J. Goldberg, MD, FAAD
UpToDate, Inc – Other(Fees);
Daniel Melo, MD, MS, PhD, IFAAD
No financial relationships exist with ineligible companies.
Paulo Müller Ramos, MD, IFAAD
Ache Laboratório Farmaceuticso S.A. – Advisory Board(Fees); Eurofarma – Advisory Board(Fees); Farmoquímica S.A. (FQM) – Speaker(Fees); Hair Science Brazil – Founder(Honoraria); L'Oreal – Advisory Board(Fees); Pfizer Inc. – Advisory Board(Fees); TheraSkin Farmacêutica – Speaker(Fees); VeraDermics Inc. – Advisory Board(Fees);
Rodrigo Pirmez, MD
Ache Laboratório Farmaceuticso S.A. – Consultant(Fees); Darrow – Consultant(Fees); FotoFinder Systems GmbH – Speaker(Fees); GlaxoSmithKline Immunology – Speaker(Fees); Pfizer Inc. – Consultant(Fees);
Nicole Elaine Rogers, MD, FAAD
No financial relationships exist with ineligible companies.
Lidia Rudnicka, MD, PhD, IFAAD
La Roche-Posay Laboratoire Pharmaceutique – Speaker(Fees); Leo Pharma Inc – Speaker/Faculty Education(Fees); Pfizer Inc. – Advisory Board(Fees);
Luis Enrique Sanchez Duenas, MD
No financial relationships exist with ineligible companies.
Anastasia Therianou, MD, PhD, IFAAD
No financial relationships exist with ineligible companies.